Cargando…

Clinical Features of Olfactory Dysfunction in COVID-19 Patients

BACKGROUND: The aim of this study was to evaluate the subjective and objective olfactory function in coronavirus disease 2019 (COVID-19) patients and the effect of olfactory training. METHODS: A prospective cohort study was performed in 53 patients who recovered from COVID-19 and visited our tertiar...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Min Young, Choi, Won Suk, Lee, Seung Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185125/
https://www.ncbi.nlm.nih.gov/pubmed/34100564
http://dx.doi.org/10.3346/jkms.2021.36.e161
_version_ 1783704720713449472
author Seo, Min Young
Choi, Won Suk
Lee, Seung Hoon
author_facet Seo, Min Young
Choi, Won Suk
Lee, Seung Hoon
author_sort Seo, Min Young
collection PubMed
description BACKGROUND: The aim of this study was to evaluate the subjective and objective olfactory function in coronavirus disease 2019 (COVID-19) patients and the effect of olfactory training. METHODS: A prospective cohort study was performed in 53 patients who recovered from COVID-19 and visited our tertiary hospital. Subjective olfactory function was evaluated using the 11-point Likert scale (0–10) and the Korean version of the Questionnaire of Olfactory Disorders (QOD). Objective olfactory function was evaluated using Cross-Cultural Smell Identification Test (CC-SIT). Confirmed patients were followed up after 2 months of olfactory training. RESULTS: The median, interquartile range (Q1–Q3) score of subjective olfactory function significantly deteriorated in patients with olfactory dysfunction (OD) than in those without OD, even after 3 months of onset (11-point Likert scale, 8, 6–9 vs. 10, 10–10; short version of QOD-negative statements, 19, 16–21 vs. 21, 21–21; QOD-visual analogue scale, 7, 1–13 vs. 0, 0–0; all P < 0.001). However, the objective olfactory function was not significantly different between the two groups (median, interquartile range; 11, 9–11 vs. 11, 9–11, P = 0.887). The percentage of patients with objective hyposmia (CC-SIT ≤ 10) was also not significantly different (47.4% vs. 40%, P = 0.762). OD in COVID-19 was normalized after 2 months of olfactory training in 70% of patients even after 3 months of olfactory impairment. CONCLUSION: Although subjective olfactory function is significantly decreased in the OD group, the objective olfactory function was not significantly different. Moreover, olfactory training is effective in COVID-19 patients with OD.
format Online
Article
Text
id pubmed-8185125
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Korean Academy of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-81851252021-06-15 Clinical Features of Olfactory Dysfunction in COVID-19 Patients Seo, Min Young Choi, Won Suk Lee, Seung Hoon J Korean Med Sci Original Article BACKGROUND: The aim of this study was to evaluate the subjective and objective olfactory function in coronavirus disease 2019 (COVID-19) patients and the effect of olfactory training. METHODS: A prospective cohort study was performed in 53 patients who recovered from COVID-19 and visited our tertiary hospital. Subjective olfactory function was evaluated using the 11-point Likert scale (0–10) and the Korean version of the Questionnaire of Olfactory Disorders (QOD). Objective olfactory function was evaluated using Cross-Cultural Smell Identification Test (CC-SIT). Confirmed patients were followed up after 2 months of olfactory training. RESULTS: The median, interquartile range (Q1–Q3) score of subjective olfactory function significantly deteriorated in patients with olfactory dysfunction (OD) than in those without OD, even after 3 months of onset (11-point Likert scale, 8, 6–9 vs. 10, 10–10; short version of QOD-negative statements, 19, 16–21 vs. 21, 21–21; QOD-visual analogue scale, 7, 1–13 vs. 0, 0–0; all P < 0.001). However, the objective olfactory function was not significantly different between the two groups (median, interquartile range; 11, 9–11 vs. 11, 9–11, P = 0.887). The percentage of patients with objective hyposmia (CC-SIT ≤ 10) was also not significantly different (47.4% vs. 40%, P = 0.762). OD in COVID-19 was normalized after 2 months of olfactory training in 70% of patients even after 3 months of olfactory impairment. CONCLUSION: Although subjective olfactory function is significantly decreased in the OD group, the objective olfactory function was not significantly different. Moreover, olfactory training is effective in COVID-19 patients with OD. The Korean Academy of Medical Sciences 2021-05-26 /pmc/articles/PMC8185125/ /pubmed/34100564 http://dx.doi.org/10.3346/jkms.2021.36.e161 Text en © 2021 The Korean Academy of Medical Sciences. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Seo, Min Young
Choi, Won Suk
Lee, Seung Hoon
Clinical Features of Olfactory Dysfunction in COVID-19 Patients
title Clinical Features of Olfactory Dysfunction in COVID-19 Patients
title_full Clinical Features of Olfactory Dysfunction in COVID-19 Patients
title_fullStr Clinical Features of Olfactory Dysfunction in COVID-19 Patients
title_full_unstemmed Clinical Features of Olfactory Dysfunction in COVID-19 Patients
title_short Clinical Features of Olfactory Dysfunction in COVID-19 Patients
title_sort clinical features of olfactory dysfunction in covid-19 patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185125/
https://www.ncbi.nlm.nih.gov/pubmed/34100564
http://dx.doi.org/10.3346/jkms.2021.36.e161
work_keys_str_mv AT seominyoung clinicalfeaturesofolfactorydysfunctionincovid19patients
AT choiwonsuk clinicalfeaturesofolfactorydysfunctionincovid19patients
AT leeseunghoon clinicalfeaturesofolfactorydysfunctionincovid19patients